Cargando…

Comparative Activities of Novel Therapeutic Agents against Molecularly Characterized Clinical Carbapenem-Resistant Enterobacterales Isolates

Limited treatment options exist for the treatment of carbapenem-resistant Enterobacterales (CRE) bacteria. Fortunately, there are several recently approved antibiotics indicated for CRE infections. Here, we examine the in vitro activity of various novel agents (eravacycline, plazomicin, ceftazidime-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teo, Jocelyn Qi-Min, Chang, Hong Yi, Tan, Si Hui, Tang, Cheng Yee, Ong, Rick Twee-Hee, Ko, Karrie Kwan Ki, Chung, Shimin Jasmine, Tan, Thuan Tong, Kwa, Andrea Lay-Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269625/ https://www.ncbi.nlm.nih.gov/pubmed/37184408 http://dx.doi.org/10.1128/spectrum.01002-23

Ejemplares similares

In Vitro Susceptibility to Ceftazidime-Avibactam and Comparator Antimicrobial Agents of Carbapenem-Resistant Enterobacterales Isolates
por: Lim, Tze-Peng, et al.
Publicado: (2023)

Genomic characterization of carbapenem-non-susceptible Pseudomonas aeruginosa in Singapore
por: Teo, Jocelyn Qi-Min, et al.
Publicado: (2021)

Ceftolozane/Tazobactam Resistance and Mechanisms in Carbapenem-Nonsusceptible Pseudomonas aeruginosa
por: Teo, Jocelyn Qi-Min, et al.
Publicado: (2021)

Carbapenem Resistance in Gram-Negative Bacteria: The Not-So-Little Problem in the Little Red Dot
por: Teo, Jocelyn Qi Min, et al.
Publicado: (2016)

Treatment and Outcomes of Infections Caused by Diverse Carbapenemase-Producing Carbapenem-Resistant Enterobacterales
por: Lim, Fang Kang, et al.
Publicado: (2020)

Genomic Surveillance of Carbapenem-Resistant Klebsiella pneumoniae from a Major Public Health Hospital in Singapore
por: Teo, Jocelyn Qi-Min, et al.
Publicado: (2022)

Risk Factors, Molecular Epidemiology and Outcomes of Ertapenem-Resistant, Carbapenem-Susceptible Enterobacteriaceae: A Case-Case-Control Study
por: Teo, Jocelyn, et al.
Publicado: (2012)

In vitro Bactericidal Activities of Combination Antibiotic Therapies Against Carbapenem-Resistant Klebsiella pneumoniae With Different Carbapenemases and Sequence Types
por: Teo, Jocelyn Qi-Min, et al.
Publicado: (2021)

Using an Adenosine Triphosphate Bioluminescent Assay to Determine Effective Antibiotic Combinations against Carbapenem-Resistant Gram Negative Bacteria within 24 Hours
por: Cai, Yiying, et al.
Publicado: (2015)

Estimating the economic cost of carbapenem resistant Enterobacterales healthcare associated infections in Singapore acute-care hospitals
por: Cai, Yiying, et al.
Publicado: (2022)

Whole genome sequencing of multidrug resistant Enterobacterales identified in children and their household members within Siem Reap, Cambodia
por: Singh, Shweta R, et al.
Publicado: (2023)

Predictors and Outcomes of Healthcare-Associated Infections Caused by Carbapenem-Nonsusceptible Enterobacterales: A Parallel Matched Case-Control Study
por: Hoo, Grace S. R., et al.
Publicado: (2022)

Screening for Metallo-Beta-Lactamases Using Non-Carbapenem Agents: Effective Detection of MBL-Producing Enterobacterales and Differentiation of Carbapenem-Resistant Enterobacterales
por: Takei, Kentarou, et al.
Publicado: (2023)

Integrated pharmacokinetic–pharmacodynamic modeling to evaluate empiric carbapenem therapy in bloodstream infections
por: Lim, Tze-Peng, et al.
Publicado: (2018)

708. Incidence and Relatedness of Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Infections in Previously Colonized or Infected Patients
por: Tang, Sarah Si Lin, et al.
Publicado: (2018)

Elimination of Extracellular Adenosine Triphosphate for the Rapid Prediction of Quantitative Plate Counts in 24 h Time-Kill Studies against Carbapenem-Resistant Gram-Negative Bacteria
por: Cai, Yiying, et al.
Publicado: (2020)

In-Vitro Activity of Polymyxin B, Rifampicin, Tigecycline Alone and in Combination against Carbapenem-Resistant Acinetobacter baumannii in Singapore
por: Lim, Tze-Peng, et al.
Publicado: (2011)

Activity of mecillinam against carbapenem-resistant Enterobacterales
por: Emeraud, Cécile, et al.
Publicado: (2022)

Updates on the Status of Carbapenem-Resistant Enterobacterales in Lebanon
por: Fadlallah, Mahdi, et al.
Publicado: (2023)

Antimicrobial stewardship programme: a vital resource for hospitals during the global outbreak of coronavirus disease 2019 (COVID-19)
por: Liew, Yixin, et al.
Publicado: (2020)

An Overview on Phenotypic and Genotypic Characterisation of Carbapenem-Resistant Enterobacterales
por: Rabaan, Ali A., et al.
Publicado: (2022)

Relating knowledge, attitude and practice of antibiotic use to extended-spectrum beta-lactamase-producing Enterobacteriaceae carriage: results of a cross-sectional community survey
por: Mo, Yin, et al.
Publicado: (2019)

The carbapenem inoculum effect provides insight into the molecular mechanisms underlying carbapenem resistance in Enterobacterales
por: Cartagena, Alexis Jaramillo, et al.
Publicado: (2023)

588. Ceftolozane/Tazobactam Susceptibility of Carbapenem-Resistant Pseudomonas aeruginosa and Carbapenem-Resistant Enterobacterales Isolates in a Tertiary Hospital in Korea
por: Kim, Kye-Hyung, et al.
Publicado: (2023)

In silico region of difference (RD) analysis of Mycobacterium tuberculosis complex from sequence reads using RD-Analyzer
por: Faksri, Kiatichai, et al.
Publicado: (2016)

Community-acquired viral respiratory infections amongst hospitalized inpatients during a COVID-19 outbreak in Singapore: co-infection and clinical outcomes
por: Wee, Liang En, et al.
Publicado: (2020)

Clinical Experience with High-Dose Polymyxin B against Carbapenem-Resistant Gram-Negative Bacterial Infections—A Cohort Study
por: Cai, Yiying, et al.
Publicado: (2020)

Molecular characterization of clinical carbapenem-resistant Enterobacterales from Qatar
por: Abid, Fatma Ben, et al.
Publicado: (2021)

Molecular epidemiology of carbapenem-resistant Enterobacterales in Thailand, 2016–2018
por: Paveenkittiporn, Wantana, et al.
Publicado: (2021)

Poor outcomes in both infection and colonization with carbapenem-resistant Enterobacterales
por: Howard-Anderson, Jessica R., et al.
Publicado: (2022)

Molecular epidemiology and outcome of carbapenem-resistant Enterobacterales in Saudi Arabia
por: Alraddadi, Basem M., et al.
Publicado: (2022)

Monitoring Carbapenem-Resistant Enterobacterales in the Environment to Assess the Spread in the Community
por: Urase, Taro, et al.
Publicado: (2022)

Early Years of Carbapenem-Resistant Enterobacterales Epidemic in Abu Dhabi
por: Pál, Tibor, et al.
Publicado: (2022)

Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure
por: Rebold, Nicholas, et al.
Publicado: (2023)

Carbapenem-Resistant and ESBL-Producing Enterobacterales Emerging in Central Texas
por: Parker, Jennifer K, et al.
Publicado: (2023)

A Review of Carbapenem Resistance in Enterobacterales and Its Detection Techniques
por: Caliskan-Aydogan, Oznur, et al.
Publicado: (2023)

SpoTyping: fast and accurate in silico Mycobacterium spoligotyping from sequence reads
por: Xia, Eryu, et al.
Publicado: (2016)

Carbapenem-Resistant Enterobacterales in Long-Term Care Facilities: A Global and Narrative Review
por: Chen, Hsin-Yu, et al.
Publicado: (2021)

Epidemiology of Extended-Spectrum Beta-Lactamase and Carbapenemase-Producing Enterobacterales in the Greater Mekong Subregion: A Systematic-Review and Meta-Analysis of Risk Factors Associated With Extended-Spectrum Beta-Lactamase and Carbapenemase Isolation
por: Singh, Shweta R., et al.
Publicado: (2021)

Effective Antibiotics in Combination against Extreme Drug-Resistant Pseudomonas aeruginosa with Decreased Susceptibility to Polymyxin B
por: Lim, Tze-Peng, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_c7a102rl5nfvschtmlltes3lp1